Opinion
verabschiedet on 12/12/2012
Referenz:
INT/658-EESC-2012-2059Referral:
COM(2012) 369 final - 2012/0192 (COD)Rapporteur:
Plenartagung:
485 -
Dez 12, 2012 Dez 13, 2012
Arzneimittel
Displaying 11 - 20 of 27
Pages
Opinion
verabschiedet on 12/07/2012
Referenz:
INT/642-EESC-2012-1573Referral:
COM(2012) 84 final - 2012/0035 (COD)Rapporteur:
Plenartagung:
482 -
Jul 11, 2012 Jul 12, 2012
Opinion
verabschiedet on 28/03/2012
Referenz:
INT/639-EESC-2012-812Referral:
COM(2012) 51 final - 2012/0023 (COD)Plenartagung:
479 -
Mar 28, 2012 Mar 29, 2012
Opinion
verabschiedet on 28/03/2012
Referenz:
INT/638-EESC-2012-811Referral:
COM(2012) 52 final - 2012/0025 (COD)Plenartagung:
479 -
Mar 28, 2012 Mar 29, 2012
Opinion
verabschiedet on 28/03/2012
Referenz:
INT/637-EESC-2012-810Referral:
COM(2012) 49 final - 2008/0255 (COD)Plenartagung:
479 -
Mar 28, 2012 Mar 29, 2012
Opinion
verabschiedet on 28/03/2012
Referenz:
INT/636-EESC-2012-809Referral:
COM(2012) 48 final - 2008/0256 (COD)Plenartagung:
479 -
Mar 28, 2012 Mar 29, 2012
Opinion
verabschiedet on 22/02/2012
Referenz:
INT/602-EESC-2012-469Referral:
COM(2011) 633 final - 2008/0256 (COD)Plenartagung:
478 -
Feb 22, 2012 Feb 23, 2012
Opinion
verabschiedet on 22/02/2012
Referenz:
INT/601-EESC-2012-468Referral:
COM(2011) 632 final - 2008/0255 (COD)Plenartagung:
478 -
Feb 22, 2012 Feb 23, 2012
Opinion
verabschiedet on 30/09/2009
Referenz:
INT/478-EESC-2009-1456Referral:
COM(2008) 666 finalRapporteur:
Plenartagung:
456 -
Sep 30, 2009 Oct 01, 2009